Skip to main content
ABION Inc. logo

ABION Inc. — Investor Relations & Filings

Ticker · 203400 ISIN · KR7203400007 KO Professional, scientific and technical activities
Open in API
Filings indexed 409 across all filing types
Latest filing 2019-05-16 Major Shareholding Noti…
Country KR South Korea
Listing KO 203400

About ABION Inc.

https://abionbio.com/en/

ABION Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative medicines, focusing on first-in-class and best-in-class therapeutics for oncology and viral diseases. The company's lead oncology asset is ABN401, a selective c-Met tyrosine kinase inhibitor (TKI) designed to treat non-small cell lung cancer (NSCLC) with MET mutations, which has shown a favorable safety profile. Another key pipeline candidate is ABN501, a novel monoclonal antibody targeting Claudin-3 for various cancers. Beyond oncology, ABION is developing ABN101, a second-generation Interferon-β formulated as a broad-spectrum anti-viral inhaler for respiratory infections. The company aims to commercialize its assets in global markets through internationally recognized clinical processes.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details changes in share ownership, specifically reporting a major shareholding notification (crossing thresholds) and related party transactions. It fits the definition of a Major Shareholding Notification (MRQ) as it tracks significant changes in ownership levels and reports them to the regulatory body.
2019-05-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often referred to as the '5% rule' or 'insider ownership report') to report shareholdings and changes in holdings by company insiders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers reports of share transactions or ownership status by company directors and executives.
2019-05-16 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a formal notice announcing an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into other specific categories like earnings releases or financial reports, it is classified as a Regulatory Filing (RNS) as it serves as a standard corporate disclosure notice.
2019-05-13 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision for a third-party capital increase (유상증자결정) by Abion Inc. This type of regulatory filing in the Korean market, which details share issuance, pricing, and allocation to third parties, falls under the category of share issuance and capital changes.
2019-05-10 Korean
최대주주변경을수반하는주식양수도계약체결
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing regarding a change in the company's largest shareholder due to a stock purchase agreement. This type of disclosure, involving a change in control or major shareholding structure, is classified under 'Major Shareholding Notification' (MRQ) as it details the transfer of shares between the current and future largest shareholders.
2019-05-09 Korean
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 12th fiscal year (2018) of Abion Inc. It contains comprehensive information including company overview, history, capital changes, shareholder status, and detailed business descriptions. This is a standard annual regulatory filing in South Korea, which corresponds to the 10-K category in the provided schema. FY 2018
2019-04-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.